Medication info
Primonol Tablets 40 mg (Telmisartan)

Primonol Tablets 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
White or almost white, biconvex round tablet
Packaging
10 tablets/blister × 3
Approval status
Active

MFDS item code 201907890 · Approved 2019.11.13 · Insurance code 653405080

Summary

Main use
Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension. Additionally, it helps reduce the risk of myocardial infarction, stroke, and cardiovascular mortality in patients aged 55 and older who are at high risk for cardiovascular diseases such as coronary artery disease, peripheral artery disease, and transient ischemic attacks. It can be safely administered to patients who cannot use ACE inhibitors. Thus, this medication plays an important role not only in hypertension treatment but also in preventing high-risk cardiovascular diseases, improving and protecting the patient’s cardiovascular health.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Patients with an allergy to this medication or severely impaired liver function, pregnant or nursing women, and patients with a history of certain kidney diseases or angioedema should not use it. Elderly patients or those with hyperkalemia, mild to moderate liver impairment, and certain other conditions should use this medication with caution, as it may cause blood pressure to drop too low. While taking this medication, regular monitoring of blood pressure, kidney function, and serum potassium levels is necessary to ensure no abnormalities occur. Special caution is warranted for diabetic patients or those with impaired kidney function due to the risk of hyperkalemia and worsening kidney function. This medication may interact with other antihypertensive drugs or certain medications, so all medications being taken should be disclosed to healthcare providers. If symptoms such as dizziness, fainting, difficulty breathing, or swelling of the face or lips occur while taking this medication, consult with healthcare personnel immediately. This medication is not recommended for children as safety and efficacy have not been established, and caution should be exercised when administering to the elderly to prevent excessively low blood pressure. In case of overdose, symptoms such as hypotension, dizziness, and acute kidney failure may occur, necessitating appropriate treatment at a hospital; this medication is not removed by hemodialysis, so caution is required. Keep this medication out of reach of children, and do not open the package until ready to use. Finally, this medication contains sorbitol, making it unsuitable for patients with hereditary fructose intolerance.

Side effects

  • Upper respiratory tract infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 110 more
  • anaphylactic reactions
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver disorder
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin eruption
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute kidney failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • elevated serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • asthenia
  • hunger
  • cold sweat
  • hand tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • oropharyngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • respiratory distress
  • laryngeal edema
  • interstitial pneumonia
  • fever
  • pneumonia
  • rhabdomyolysis
  • myalgia
  • elevated creatine kinase
  • increased serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • headache
  • dizziness
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • decreased appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • arrhythmia
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Additionally, it is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This way, the efficacy of the medication can be well preserved and deterioration prevented.

Appearance and packaging

Appearance

White or almost white, biconvex round tablet

Package unit

10 tablets/blister × 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.